We are live on ! Find out more
CI Investments Inc

CI Investments Inc Portfolio holdings

AUM $20.6B
1-Year Est. Return 29.22%
This Fund
S&P 500
This Quarter Est. Return
+9.11%
1 Year Est. Return
+29.22%
3 Year Est. Return
+102.33%
5 Year Est. Return
+125.33%
10 Year Est. Return
+439.34%
AUM
$19.8B
AUM Growth
-$54.3M
Cap. Flow
-$1.42B
Cap. Flow %
-7.19%
Top 10 Hldgs %
26.71%
Holding
1,363
New
63
Increased
806
Reduced
406
Closed
55

Top Buys

Rank Stock Value
1
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$221M
2
NVDA icon
NVIDIA
NVDA
+$76M
3
NOW icon
ServiceNow
NOW
+$67.5M
4
LLY icon
Eli Lilly
LLY
+$64.2M
5
SRE icon
Sempra
SRE
+$49.2M

Sector Composition

Rank Sector Weight
1 Technology 21.9%
2 Financials 13.33%
3 Healthcare 12.87%
4 Consumer Discretionary 8.65%
5 Communication Services 8.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPRT icon
751
Copart
CPRT
$27.5B
$115K ﹤0.01%
2,526
+258
+11% +$10.7K
FDS icon
752
Factset
FDS
$10.2B
$115K ﹤0.01%
288
+9
+3% +$3.63K
NUE icon
753
Nucor
NUE
$62.1B
$115K ﹤0.01%
701
+26
+4% +$3.8K
NVST icon
754
Envista
NVST
$4.52B
$115K ﹤0.01%
3,392
+1,962
+137% +$69.2K
ITT icon
755
ITT
ITT
$19.1B
$113K ﹤0.01%
1,214
+94
+8% +$7.89K
KMI icon
756
Kinder Morgan
KMI
$68.7B
$113K ﹤0.01%
6,580
+84
+1% +$1.43K
NI icon
757
NiSource
NI
$20.4B
$112K ﹤0.01%
4,112
+369
+10% +$10.2K
TFC icon
758
Truist Financial
TFC
$64B
$112K ﹤0.01%
3,697
+206
+6% +$6.4K
NTLA icon
759
Intellia Therapeutics
NTLA
$1.67B
$111K ﹤0.01%
2,710
+340
+14% +$13.8K
TAP icon
760
Molson Coors Class B
TAP
$8.09B
$111K ﹤0.01%
1,691
+159
+10% +$9.83K
WELL icon
761
Welltower
WELL
$171B
$111K ﹤0.01%
1,368
+115
+9% +$8.86K
FORG
762
DELISTED
ForgeRock, Inc.
FORG
$111K ﹤0.01%
5,396
+745
+16% +$14.9K
DOC icon
763
Healthpeak Properties
DOC
$14.8B
$110K ﹤0.01%
5,464
-18,148
-77% -$377K
O icon
764
Realty Income
O
$59.1B
$110K ﹤0.01%
1,842
+184
+11% +$11.2K
UDR icon
765
UDR
UDR
$12.3B
$110K ﹤0.01%
2,562
+48
+2% +$1.98K
ALLY icon
766
Ally Financial
ALLY
$13.3B
$109K ﹤0.01%
4,032
+170
+4% +$4.52K
ATR icon
767
AptarGroup
ATR
$8.61B
$109K ﹤0.01%
943
+82
+10% +$9.61K
CRSP icon
768
CRISPR Therapeutics
CRSP
$5.17B
$108K ﹤0.01%
1,919
-230
-11% -$13.1K
LPLA icon
769
LPL Financial
LPLA
$28.6B
$108K ﹤0.01%
497
-37,787
-99% -$7.57M
PACB icon
770
Pacific Biosciences
PACB
$370M
$108K ﹤0.01%
8,153
-773
-9% -$9.39K
BWXT icon
771
BWX Technologies
BWXT
$15.6B
$107K ﹤0.01%
1,501
+103
+7% +$6.73K
CIVI
772
DELISTED
Civitas Resources
CIVI
$107K ﹤0.01%
1,549
+14
+0.9% +$968
LHX icon
773
L3Harris
LHX
$53.4B
$106K ﹤0.01%
542
-367
-40% -$70.2K
OTIS icon
774
Otis Worldwide
OTIS
$28.2B
$106K ﹤0.01%
1,190
+87
+8% +$7.33K
DOW icon
775
Dow Inc
DOW
$21.2B
$105K ﹤0.01%
1,965
+105
+6% +$5.58K

Similar funds

CI Investments Inc's Q2 2023 Portfolio in Review

As of Q2 2023, CI Investments Inc held 1,363 positions worth $19.8B, down 0.27% from $19.9B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

CI Investments Inc withdrew a net $1.42B in Q2 2023, closing 55 positions and reducing 406 holdings. Its most notable exit was SiriusPoint, an estimated $3.95M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

Against the trend, CI Investments Inc opened a new position in Novo Nordisk worth $19.8M.

  • CI Investments Inc's largest Q2 2023 buy was Novo Nordisk: 244,454 shares worth $19.8M.
  • CI Investments Inc added most to iShares 20+ Year Treasury Bond ETF in Q2 2023, an estimated $221M increase.
  • CI Investments Inc's biggest Q2 2023 reduction was Microsoft, cutting an estimated $128M.
  • CI Investments Inc fully exited SiriusPoint in Q2 2023, selling an estimated $3.95M.
  • CI Investments Inc's ten largest holdings make up 27% of its $19.8B portfolio in Q2 2023.
  • CI Investments Inc opened 63 new positions and closed 55 in Q2 2023.
  • CI Investments Inc's portfolio value fell 0.27% quarter-over-quarter to $19.8B.

Based on CI Investments Inc's 13F filing for Q2 2023, filed 11 Aug 2023.